An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Small Cell Lung Cancer

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

February 13, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
CancerNon-small Cell Lung Cancer (NSCLC)
Interventions
DRUG

Cofetuzumab Pelidotin

Intravenous (IV) infusion

Trial Locations (26)

333

Linkou Chang Gung Memorial Hospital /ID# 222603, Taoyuan

704

National Cheng Kung University Hospital /ID# 222602, Tainan City

13496

CHA Bundang Medical Center /ID# 232514, Seongnam

22031

Virginia Cancer Specialists - Fairfax /ID# 216427, Fairfax

28040

Hospital Universitario Fundacion Jimenez Diaz /ID# 215110, Madrid

28050

Hospital Universitario HM Sanchinarro /ID# 215102, Madrid

35233

University of Alabama at Birmingham - Main /ID# 213605, Birmingham

37203

Tennessee Oncology, PLLC /ID# 215326, Nashville

63110

Washington University-School of Medicine /ID# 213453, St Louis

72762

Highlands Oncology Group, PA /ID# 215383, Springdale

77030

University of Texas MD Anderson Cancer Center /ID# 215876, Houston

80045

Univ of Colorado Cancer Center /ID# 215295, Aurora

3109601

Rambam Health Care Campus /ID# 217536, Haifa

4941492

Rabin Medical Center /ID# 217537, Petah Tikva

5265601

The Chaim Sheba Medical Center /ID# 217538, Ramat Gan

94305-2200

Duplicate_Stanford University School of Med /ID# 213450, Stanford

33136-1002

Sylvester Comprehensive Cancer Center /ID# 216433, Miami

33612-9416

Moffitt Cancer Center /ID# 215101, Tampa

43210-1257

The Ohio State University /ID# 211088, Columbus

77030-3306

Oncology Consultants /ID# 215932, Houston

277-8577

National Cancer Center Hospital East /ID# 218537, Kashiwa-shi

104-0045

National Cancer Center Hospital /ID# 218536, Chuo-ku

05505

Asan Medical Center /ID# 222280, Seoul

06351

Samsung Medical Center /ID# 222906, Seoul

03722

Yonsei University Health System Severance Hospital /ID# 222281, Seoul

08035

Hospital Universitario Vall d'Hebron /ID# 215729, Barcelona

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

AbbVie

INDUSTRY